Cargando…

Plasma proGRP Concentration is Sensitive and Specific for Discriminating Small Cell Lung Cancer from Nonmalignant Conditions or Non-small Cell Lung Cancer

To date, most clinical data on pro-gastrin-releasing peptide (proGRP) have been based on serum concentrations. This study evaluated the agreement between proGRP levels in fresh serum and plasma in patients with various lung diseases. Pairs of serum and EDTA plasma were collected from 49 healthy indi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Hye-Ran, Oh, In-Jae, Shin, Myung-Geun, Park, Joon-Seok, Choi, Hyun-Jung, Ban, Hee-Jung, Kim, Kyu-Sik, Kim, Young-Chul, Shin, Jong-Hee, Ryang, Dong-Wook, Suh, Soon-Pal
Formato:	Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082113/ https://www.ncbi.nlm.nih.gov/pubmed/21532852 http://dx.doi.org/10.3346/jkms.2011.26.5.625

Ejemplares similares

ProGRP as early predictive marker of non–small-cell lung cancer to small-cell lung cancer transformation after EGFR-TKI treatment
por: Kato, Yasuhiro, et al.
Publicado: (2019)

Evaluating the diagnostic and prognostic value of serum TuM2‐PK, NSE, and ProGRP in small cell lung cancer
por: Li, Li, et al.
Publicado: (2023)

Pro-gastrin-releasing peptide (ProGRP) as a biomarker in small-cell lung cancer diagnosis, monitoring and evaluation of treatment response
por: Wojcik, Ewa, et al.
Publicado: (2017)

Serum ProGRP and NSE levels predicting small cell lung cancer transformation in a patient with ALK rearrangement-positive non-small cell lung cancer: A case report
por: Oya, Yuko, et al.
Publicado: (2018)

Detection of CEA and ProGRP Levels in BALF of Patients with Peripheral Lung Cancer and Their Relationship with CT Signs
por: Tian, Kui, et al.
Publicado: (2022)

Detection of Changes in CEA and ProGRP Levels in BALF of Patients with Peripheral Lung Cancer and the Relationship with CT Signs
por: Huang, Jingshan, et al.
Publicado: (2023)

High Sensitive Immunoelectrochemical Measurement of Lung Cancer Tumor Marker ProGRP Based on TiO(2)-Au Nanocomposite
por: Wei, Zheng, et al.
Publicado: (2019)

Utility of the Serum ProGRP Level for Follow-up of Pulmonary Carcinoid Tumors
por: Taira, Naohiro, et al.
Publicado: (2014)

Effects of Bevacizumab Combined with Chemotherapy on CT, CyFRA21-1, and ProGRP and Prognosis of Lung Cancer Patients under Nursing Intervention
por: Xi, Chao, et al.
Publicado: (2022)

Bilateral Internal Auditory Canal Metastasis of Non-small Cell Lung Cancer
por: Kim, Chang-Hee, et al.
Publicado: (2015)

Retracted: Effects of Bevacizumab Combined with Chemotherapy on CT, CyFRA21-1, and ProGRP and Prognosis of Lung Cancer Patients under Nursing Intervention
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

ProGRP与NSE对小细胞肺癌诊断价值的meta分析
Publicado: (2010)

Evaluation of chemiluminescent immunoassay quantitative detection for pro-gastrin-releasing peptide (ProGRP) in serum and plasma
por: Cheng, Yizhuang, et al.
Publicado: (2019)

Emerging role of LETM1/GRP78 axis in lung cancer
por: Tran, Quangdon, et al.
Publicado: (2022)

血清NSE、ProGRP和LDH在小细胞肺癌诊断治疗中的作用
Publicado: (2016)

Cancer Testis Antigen, NOL4, Is an Immunogenic Antigen Specifically Expressed in Small-Cell Lung Cancer
por: Kim, Ye-Rin, et al.
Publicado: (2021)

Epidermal Growth Factor Receptor (EGFR) Expression in Operable Non-small Cell Lung Carcinoma
por: Ahn, Jin-Hee, et al.
Publicado: (2004)

Surgical Outcomes in Small Cell Lung Cancer
por: Ju, Min Ho, et al.
Publicado: (2012)

Intraoperative photodynamic therapy for tracheal mass in non-small cell lung cancer: A case report
por: Jung, Hee Suk, et al.
Publicado: (2023)

CXCR4 uses STAT3-mediated slug expression to maintain radioresistance of non-small cell lung cancer cells: emerges as a potential prognostic biomarker for lung cancer
por: Kim, Jeong-Yub, et al.
Publicado: (2021)

Evaluation of Two EGFR Mutation Tests on Tumor and Plasma from Patients with Non-Small Cell Lung Cancer
por: Kim, Jeong-Oh, et al.
Publicado: (2020)

GRP78 in lung cancer
por: Xia, Shengkai, et al.
Publicado: (2021)

Pemetrexed in Previously Treated Non-small Cell Lung Cancer Patients with Poor Performance Status
por: Sun, Young JUNG, et al.
Publicado: (2011)

Definitive surgery and intraoperative photodynamic therapy for locally advanced non-small cell lung cancer: a case report
por: Jung, Hee Suk, et al.
Publicado: (2022)

Mitochondrial DNA Aberrations of Bone Marrow Cells from Patients with Aplastic Anemia
por: Kim, Hye-Ran, et al.
Publicado: (2008)

Activation of caspases and inhibition of ribosome biogenesis mediate antitumor activity of Chijongdan in A549 non-small lung cancer cells
por: Kim, Bo Geun, et al.
Publicado: (2014)

Potential Oncogenic Role of the Papillary Renal Cell Carcinoma Gene in Non-Small Cell Lung Cancers
por: Jang, Sun-Hee, et al.
Publicado: (2019)

Surgical Impacts of Metastatic Non-small Cell Lung Cancer to the Thoracic and Lumbar Spine
por: Jung, Jong-myung, et al.
Publicado: (2021)

Allelic Expression Imbalance of JAK2 V617F Mutation in BCR-ABL Negative Myeloproliferative Neoplasms
por: Kim, Hye-Ran, et al.
Publicado: (2013)

Spectra of Chromosomal Aberrations in 325 Leukemia Patients and Implications for the Development of New Molecular Detection Systems
por: Choi, Hyun-Jung, et al.
Publicado: (2011)

Effect of 5-FU and MTX on the Expression of Drug-resistance Related Cancer Stem Cell Markers in Non-small Cell Lung Cancer Cells
por: Yi, Hee, et al.
Publicado: (2012)

Seroepidemiology of Toxocariasis and Its Clinical Implications in Gwangju and Jeonnam-province, Korea
por: Won, Eun Jeong, et al.
Publicado: (2015)

The Prevalence of Human Papillomavirus Infection in Korean Non-Small Cell Lung Cancer Patients
por: Park, Moo Suk, et al.
Publicado: (2007)

Bufalin down-regulates Axl expression to inhibit cell proliferation and induce apoptosis in non-small-cell lung cancer cells
por: Kim, Nam-Yi, et al.
Publicado: (2020)

Natural Progression of Ground-glass Nodules after Curative Resection for Non-small Cell Lung Cancer
por: Lee, Kanghoon, et al.
Publicado: (2021)

Multiple Hypercoagulability Disorders at Presentation of Non-Small-Cell Lung Cancer
por: Lee, Jeong Min, et al.
Publicado: (2014)

Evaluation of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry-Based VITEK MS System for the Identification of Acinetobacter Species from Blood Cultures: Comparison with VITEK 2 and MicroScan Systems
por: Lee, Seung Yeob, et al.
Publicado: (2015)

Robot-Assisted Thoracic Surgery in Non-small Cell Lung Cancer
por: Lee, Jun Hee, et al.
Publicado: (2021)

Oncogenic KRAS mutation confers chemoresistance by upregulating SIRT1 in non-small cell lung cancer
por: Shin, Dong Hoon, et al.
Publicado: (2023)

Prognostic impact of EGFR mutation in non-small-cell lung cancer patients with family history of lung cancer
por: Kim, Jung Soo, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_kdjvraf7lve153tnlamsrumlph